At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
JOB DESCRIPTION: Primary Function Provides global or regional leadership for a particular regional or global clinical program. Ensures design and execution of high quality clinical studies to ensure safety and effectiveness of the company’s products. Manages
Position Summary The “Senior Manager, Medical Science Liaison (MSL)” is a field-based scientific expert that strategically supports the medical and scientific objectives of Alexion’s product/indication(s) across the product/s life cycle. He/she is a peer scientific
Position Summary The “Senior Manager, Medical Science Liaison (MSL)” is a field-based scientific expert that strategically supports the medical and scientific objectives of Alexion’s product/indication(s) across the product/s life cycle. He/she is a peer scientific
＜Areas＞ ・Hematology & Nephrology Position Summary The “Senior Manager, Medical Science Liaison (MSL)” is a field-based scientific expert that strategically supports the medical and scientific objectives of Alexion’s product/indication(s) across the product/s life cycle. He/she